Metropolitan Life Insurance CO Dyne Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$13.06 - $29.18 $9,938 - $22,205	761 Added 32.03%	3,137 $89,000
Q2 2023 Aug 10, 2023	BUY	$8.53 - $14.28 $2,780 - $4,655	326 Added 15.9%	2,376 $26,000
Q4 2022 Mar 30, 2023	SELL	$9.37 - $13.8 $4,984 - $7,341	-532 Reduced 20.6%	2,050 $23,000
Q4 2022 Feb 15, 2023	SELL	$9.37 - $13.8 $4,984 - $7,341	-532 Reduced 20.6%	2,050 $23,000
Q3 2022 Jun 14, 2023	BUY	$7.2 - $15.17 $3,830 - $8,070	532 Added 25.95%	2,582 $32.8 Million
Q2 2022 Jun 20, 2023	BUY	$4.36 - $10.5 $2,319 - $5,586	532 Added 25.95%	2,582 $17,000
Q1 2022 Jun 20, 2023	BUY	$6.52 - $12.27 $3,468 - $6,527	532 Added 25.95%	2,582 $24,000
Q1 2022 Mar 30, 2023	SELL	$6.52 - $12.27 $46,813 - $88,098	-7,180 Reduced 73.55%	2,582 $24,000
Q1 2022 May 12, 2022	SELL	$6.52 - $12.27 $46,813 - $88,098	-7,180 Reduced 73.55%	2,582 $25,000
Q4 2021 Jun 21, 2023	BUY	$11.89 - $16.07 $91,695 - $123,931	7,712 Added 376.2%	9,762 $116,000
Q4 2021 Mar 30, 2023	BUY	$11.89 - $16.07 $32,400 - $43,790	2,725 Added 38.72%	9,762 $116,000
Q4 2021 Feb 15, 2022	BUY	$11.89 - $16.07 $32,400 - $43,790	2,725 Added 38.72%	9,762 $116,000
Q3 2021 Jun 21, 2023	BUY	$15.6 - $21.46 $77,797 - $107,021	4,987 Added 243.27%	7,037 $114,000
Q3 2021 Mar 30, 2023	SELL	$15.6 - $21.46 $34,008 - $46,782	-2,180 Reduced 23.65%	7,037 $114,000
Q3 2021 Nov 15, 2021	SELL	$15.6 - $21.46 $34,008 - $46,782	-2,180 Reduced 23.65%	7,037 $114,000
Q2 2021 Jun 21, 2023	BUY	$15.94 - $22.33 $114,241 - $160,039	7,167 Added 349.61%	9,217 $193,000
Q2 2021 Mar 30, 2023	BUY	$15.94 - $22.33 $63,616 - $89,119	3,991 Added 76.37%	9,217 $193,000
Q2 2021 Aug 16, 2021	BUY	$15.94 - $22.33 $146,918 - $205,815	9,217 New	9,217 $194,000
Q1 2021 May 14, 2021	SELL	$14.0 - $29.3 $73,164 - $153,121	-5,226 Closed	0 $0
Q4 2020 Jun 22, 2023	BUY	$16.81 - $23.94 $53,388 - $76,033	3,176 Added 154.93%	5,226 $109,000
Q4 2020 Mar 30, 2023	BUY	$16.81 - $23.94 $53,388 - $76,033	3,176 Added 154.93%	5,226 $109,000
Q4 2020 Feb 16, 2021	BUY	$16.81 - $23.94 $87,849 - $125,110	5,226 New	5,226 $110,000

Others Institutions Holding DYN

# of Institutions

209

Shares Held

102M

Call Options Held

234K

Put Options Held

238K

Atlas Venture Life Science Advisors, LLC

8.02M
Shares

$109 Million
35.54% of portfolio
Black Rock Inc. New York, NY

7.39M
Shares

$100 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

6.86M
Shares

$92.9 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

6.82M
Shares

$92.3 Million
3.9% of portfolio
Janus Henderson Group PLC London, X0

6.81M
Shares

$92.3 Million
0.13% of portfolio

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $701M
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account